Jason Wittes
Stock Analyst at Roth Capital
(2.79)
# 1,727
Out of 5,122 analysts
61
Total ratings
50.94%
Success rate
6.07%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals | Initiates: Buy | $40 | $11.64 | +243.64% | 1 | Sep 4, 2025 | |
| SYK Stryker | Maintains: Buy | $405 → $456 | $354.12 | +28.77% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $1.26 | +1,169.84% | 2 | Mar 21, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $3.58 | +346.93% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $15.32 | +43.60% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $97.77 | -26.36% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $6.63 | +65.91% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $87.91 | +30.82% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $12.95 | +177.99% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $7.62 | +44.36% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.97 | +933.27% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $83.04 | +20.42% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.29 | +118.34% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.80 | +1,020.24% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $27.62 | +171.54% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $20.86 | +5.47% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $90.79 | +32.17% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $131.07 | +57.17% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $184.95 | -21.60% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $18.98 | -20.97% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $13.22 | +1,412.86% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $29.75 | -12.61% | 1 | Feb 22, 2017 |
ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $11.64
Upside: +243.64%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $354.12
Upside: +28.77%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $1.26
Upside: +1,169.84%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $3.58
Upside: +346.93%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $15.32
Upside: +43.60%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $97.77
Upside: -26.36%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $6.63
Upside: +65.91%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $87.91
Upside: +30.82%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $12.95
Upside: +177.99%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.62
Upside: +44.36%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $0.97
Upside: +933.27%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $83.04
Upside: +20.42%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.29
Upside: +118.34%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $0.80
Upside: +1,020.24%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $27.62
Upside: +171.54%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $20.86
Upside: +5.47%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $90.79
Upside: +32.17%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $131.07
Upside: +57.17%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $184.95
Upside: -21.60%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $18.98
Upside: -20.97%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $13.22
Upside: +1,412.86%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $29.75
Upside: -12.61%